Neuropharmacological and pharmacokinetic properties of berberine: A review of recent research

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 7, 2009, Pages 831-837

  Ye, Minzhong ^a   Fu, Sheng ^a   Pi, Rongbiao ^a   He, Feng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Berberine; Neuropharmacology; Pharmacokinetics

Indexed keywords

BERBERINE; BEROLINE; DEMETHYLENEBERBERINE; DEMETHYLENEBERBERINE 2 SULFATE; DRUG METABOLITE; JATRORRHIZINE; JATRORRHIZINE 3 SULFATE; THALIFENDINE; THALIFENDINE 10 SULFATE; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; DIABETIC NEUROPATHY; DRUG ABSORPTION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; NEUROPROTECTION; NONHUMAN; REVIEW; ANIMAL; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; BERBERINE; BRAIN ISCHEMIA; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 85047681411     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.07.0001     Document Type: Review

References (63)

1. Kupeli E et al. Comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 2002; 72: 645-657.
2. Zheng L et al. Protective effect of berberine on cardiac myocyte injured by ischemia reperfusion. Sichuan Da Xue Bao (Medicine) 2003; 34: 452-454 [in Chinese].
3. Kettmann V et al. In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. Pharmazie 2004; 59: 548-551.
4. Tran Q et al. In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine. J Ethnopharmacol 2003; 86(2-3): 249-252.
5. Racková L et al. Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifoliu. Structural aspects. Bioorg Med Chem 2003; 12: 4709-4715.
6. Ma L et al. Cerebral protective effects of some compounds isolated from traditional Chinese herbs. Chin Pharm J 1999; 24: 238-239 [in Chinese].
7. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008; 22: 999-1012.
8. Li B et al. Advances in the study of berberine and its derivatives. Yao Xue Xue Bao 2008; 43: 773-787 [in Chinese].
9. Wu JF et al. Protective effects of berberine on cultured central neuronal injuries induced by oxidative stress. Chin Pharm J 1999; 34: 525-529 [in Chinese].
10. Yoo KY et al. Berberry extract reduces neuronal damage and N-Methyl-D-aspartate receptor 1 immunoreactivity in the gerbil hippocampus after transient forebrain ischemia. Biol. Pharm Bull 2006; 29: 623-628.
11. Fan WJ et al. Protective effects of berberine on acute hypoxia induced by sodium nitrite in mice. Chin J Rehabil Theory Pract 2007; 13: 704-705 [in Chinese].
12. Wu JF et al. Protective effects of berberine on ischemic injury in cultured rat cortical neurons. Chin Pharmacol Bull 1999; 15: 243 [in Chinese].
13. Shi YJ et al. Protective effect of berberine on cerebral ischemia in mice and rats. Chin J Pharmacol Toxicol 1995; 9: 100-103 [in Chinese].
14. Wu JF et al. Protective effects of berberine on neuronal injury in cultured cortical neurons in rats. J Nanjing Med Univ 1999; 19: 84-87 [in Chinese].
15. Yokozawa T et al. Coptidis rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. J Pharm Pharmacol 2004; 56(4): 547-556.
16. Janardhan V, Qureshi AI. Mechanisms of ischemic brain injury. Curr Cardiol Rep 2004; 6: 117-123.
17. Wei YZ et al. The effects of berberine on delayed neuronal death in rat hippocampus CA-1 region. Stroke Nerv Dis 1996; 13(2): 75-77.
18. Pan LX et al. Protective effect of berberine against cerebral ischemic 'insult' in rats. Sin Guangdong Anat Bull 1995; 17(2): 81-84 [in Chinese].
19. Chen CH et al. Effect of berberine on HIF-1α expression induced by focal cerebral ischemia in rats. Acta Anatomica Sinica 2007; 38: 394-399 [in Chinese].
20. Xi GM et al. Effects of berberine on neuronal apoptosis after global cerebral ischemia in mice. J Apoplexy Nerv Dis 2004; 18: 292-294.
21. Wang F et al. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res 2004; 999: 91-97.
22. Duarte J et al. Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol 1993; 239: 1-7.
23. Xu Y et al. Effect of berberine on cerebral pial microcirculation in cerebral ischemic rats. Lishizhen Medicine and Medical Research 2001; 12: 1084-1085 [in Chinese].
24. Wu JF, Liu TP. Effect of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1a in rats with reversible middle cerebral artery occlusion. Acta Pharmacol Sin 1995; 30: 98-102 [in Chinese].
25. Jiang YY, Lung K. Platelet and ischemic cerebrovascular disease. J Cardiovasc Pharmacol 1992; 12: 4-6.
26. Yuan ZZ. Effect of Huang Lian Jie Du Tang on expression of adhesion molecules of cerebral microvascular endothelial cells during cerebral ischemia-reperfusion injury in rats. (Masters thesis) Beijing: Beijing University of Traditional Chinese Medicine, 2005 [in Chinese].
27. Terry AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 2003; 306: 821-827.
28. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
29. Tang ZM et al. Screening of acetylcholinesterase inhibitors in natural extracts by CE with electrophoretically mediated microanalysis technique. Electrophoresis 2007; 28: 360-365.
30. Cho KM et al. 8-hydroxydihydrochelerythrine and 8-hydroxydihydro-sanguinarine with a potent acetylcholinesterase inhibitory activity from Chelidonium majus. L. Biol Pharm Bull 2006; 29: 2317-2320.
31. Ingkaninan K et al. Acetylcholinesterase inhibitors from Stephania venosa tuber. J Pharm Pharmacol 2006; 58: 695-700.
32. Tan ZH et al. Effects of berberine, palmatine and total alkaloids from Rhizoma coptidis on cholinergic nerve. Pharmacol and Clinics of Chinese Materia Medica 2006; 22: 21-22 [in Chinese].
33. Shi YJ et al. Effect of berberine on function of memory and learning in mice. J Taishan Med Col 1995; 16: 83-85 [in Chinese].
34. Guo SR et al. Effects of berberine on learning and memory of mice. Chin J Herbal Pharma 1997; 13: 17-19 [in Chinese].
35. Yu DZ. Nerve agent treatment of ischemic cerebrovascular disease research progress. J Yunyang Med Coll 1999; 18: 121 [in Chinese].
36. Patel JR, Brewer GJ. Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middle-age neurons and death in old neurons. Exp Neurol 2008; 213: 93-100.
37. Yan L et al. A study of berberine in preventing and treating preclinical dementia in the aged. Practical Geriatrics 2001; 15: 30-33 [in Chinese].
38. Zhu F, Qian C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 2006; 7: 78.
39. Asai M et al. Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem Biophys Res Commun 2007; 352: 498-502.
40. Shigeta K et al. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis rhizoma extract and protoberberine alkaloids. Biosci Biotechnol Biochem 2002; 66: 2491-2494.
41. Tang GQ et al. Effect of berberine on peripheral neuropathy of type2 diabetic model rats. Modern Medicine and Public Health 2008; 24: 321-323 [in Chinese].
42. Guo HW et al. Effect of huang lian su on nerve conduction velocity and hormone level to diabetic neuropathy in rats. Labeled Immunoassays & Clin Med 2001; 8: 212-214 [in Chinese].
43. Lu JH et al. Improvement effects of berberine on glycated brain damages in rats induced by D-galactose. Chinese Traditional Patent Medicine 2006; 28: 1466-1469 [in Chinese].
44. Wang KF et al. Effect of berberine on serum β-amyloid protein in rats with type-2 DM and its mechanism. Herald of Medicine 2006; 25: 177-179 [in Chinese].
45. Peng WH et al. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci 2007; 81: 933-938.
46. Kulkarni SK, Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 2008; 589: 163-172.
47. Kong LD et al. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med 2001; 67: 74-76.
48. Peng WH et al. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors. Life Sci 2004; 75: 2451-2462.
49. Lee B et al. Coptidis rhizoma attenuates repeated nicotine-induced behavioural sensitization in the rat. J Pharm Pharmacol 2007; 59(12): 1663-1669.
50. Shen MP, Sun Q, Wang H. Studies on the intravenous pharmacokinctics and oral absorbtion of berberine hydrochlorate in beagle dogs. Chin Pharmacol Bull 1993; 9: 64-67.
51. Li BX et al. Study on the pharmacokinetics of berberine in single dosage and coadministration with oryzanol in rabbits and healthy volunteers. Chin Pharm J 2000; 35: 33-35.
52. Zuo F et al. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography ion trap mass spectrometry. Drug Metab Dispos 2006; 34: 2064-2072.
53. 3H-berberine in rabbits and mouse. Chin Pharmacol Bull 1985; 5: 293-296.
54. Wang X et al. Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci 2005; 77: 3058-3067.
55. Tsai PL, Tsai TH. Simultaneous determination of berberine in rat blood, liver and bile using microdialysis coupled to high-performance-liquid chromatography. J Chromatogr A 2002; 961: 125-130.
56. Chen CM, Chang HC. Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J Chromatogr Biomed Appl 1995; 1665: 117-123.
57. Tan B et al. Simultaneous quantification of three alkaloids of Coptidis rhizoma in rat urine by high-performance liquid chromatography: application to pharmacokinetic study. Biopharm Drug Dispos 2007; 28: 511-516.
58. Bao LH. The study of pharmacokinetics of berberine after oral administration in human. Chin Pharmacol Bull 1997; 13(1): 95 [in Chinese].
59. Pan JF et al. Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration. Acta Pharmacol Sin 2002; 23(1): 77-82.
60. Tan YZ, Xie JS. A study on the interaction of human serum albumin with berberine hydrochloride by fluorescence. Method China J of Chinese Materia Medica 1996; 21: 175-177.
61. Shitan N et al. Human MDR1 and MRP1 recognize berberine as their transport substrate. Biosci Biotechnol Biochem 2007; 71: 242-245.
62. Qiu F et al. Isolation and identification of urinary metabolites of berberine in rats and humans. Drug Metab Dispos 2008; 36(11): 2159-2165.
63. Lu T et al. Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation huang-lian-jie-du decoction and the pharmacokinetic application of the method. J Pharm Biomed Anal 2006; 40: 1218-1224.